Contributing Factors in the Pathobiology of Airway Remodeling in Obesity

Obesity Clinical Trial

Official title: Contributing Factors in the Pathobiology of Airway Remodeling in Obesity

Status Completed

Clinical Trial Summary

There are two aims for this study. The purpose of this study is to determine the effects of body weight and hormones on airway fibrosis (scarring) and lung function in obese & lean asthma subjects compared to obese & lean non-asthma subjects (Aim 1). And in obese subjects with asthma undergoing bariatric surgery compared to obese non-asthma subjects undergoing bariatric surgery (Aim 2).

Clinical Trial Description

Main Study

Specific Aim 1: Determine the effects of signaling on airway fibrosis and lung function in obese asthma and non-asthma patients. The investigators will:

•Perform assessments to determine if obese, early-onset asthma patients are more susceptible to airway fibrosis and remodeling than lean, early-onset asthma patients and obese and lean, non-asthma patients.◦

Specific Aim 2: Investigate the mechanism by which bariatric surgery slows the progression of airway fibrosis in obese human asthma. The investigators will:

•Perform assessments to determine if airway fibrosis in obese, early-onset asthma and obese non-asthma patients improves following bariatric surgery and weight loss◦ ;

Related Conditions & MeSH terms

• Airway Remodeling
• Asthma
• Bariatric Surgery Candidate
• Obesity
• Obesity, Morbid

• NCT number: NCT03115632
• Study type: Observational
• Source: Duke University
• Status: Completed
• Start date: April 9, 2018
• Completion date: June 27, 2023